Invention Grant
- Patent Title: Analyte-testing device
-
Application No.: US14732222Application Date: 2015-06-05
-
Publication No.: US09305138B2Publication Date: 2016-04-05
- Inventor: Kevin Chang
- Applicant: Bayer HealthCare LLC
- Applicant Address: CH Basel
- Assignee: Ascensia Diabetes Care Holdings AG
- Current Assignee: Ascensia Diabetes Care Holdings AG
- Current Assignee Address: CH Basel
- Agency: Nixon Peabody LLP
- Main IPC: G01N15/06
- IPC: G01N15/06 ; G01N33/00 ; G01N33/48 ; G06F19/00 ; A61B5/145 ; A61B5/00

Abstract:
A device adapted to determine an analyte concentration of a fluid sample using a test sensor. The device comprises a display adapted to display information to a user. The device further comprises at least one user-interface mechanism adapted to allow the user to interact with the device. The device further comprises a body portion including at least one opening formed therein, the at least one opening being of sufficient size to receive the test sensor. The device further comprises a memory adapted to store a plurality of stored analyte concentrations. The device further comprises a processing feature adapted to inhibit the stored analyte concentrations from being displayed on the display.
Public/Granted literature
- US20150269343A1 ANALYTE-TESTING DEVICE Public/Granted day:2015-09-24
Information query